Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial Evaluating BOT+BAL Combination in MSS/pMMR Metastatic Colorectal Cance Agenus Inc., a clinical-stage immuno-oncology company focused on developing novel therapies…
Biogen’s Acquisition of Apellis Strengthens Immunology and Rare Disease Portfolio While Accelerating Growth and Entry into Nephrology Biogen Inc. and Apellis Pharmaceuticals (Nasdaq: APLS) have announced a definitive agreement under…
Bristol Myers Squibb Strengthens and Expands Commitment to Advancing Equitable Care in Multiple Myeloma as GAAP Initiative Reaches Ten Years Bristol Myers Squibb (NYSE: BMY), a recognized leader in oncology,…
Lilly Announces Acquisition of Centessa Pharmaceuticals to Expand Pipeline in Sleep-Wake Disorder Treatments Eli Lilly and Company and Centessa Pharmaceuticals plc have announced a definitive agreement under which Lilly will…
Submissions Open for the Second Annual Thomas J. Fogarty Prize Recognizing Breakthrough Medtech Innovations Nominations are set to open on April 2, 2026, for the second annual Thomas J. Fogarty…
LumaCyte’s Analytical Method Recognized in Newly Issued ISO Global Standard for Viral Vector Quantification LumaCyte has announced a significant milestone for its proprietary analytical technology, revealing that its approach has…
Bayer Implements U.S. Leadership Restructuring in Pharmaceuticals’ Worldwide Markets to Accelerate Growth Potential Bayer has announced a significant leadership transition within its Pharmaceuticals division, signaling a strategic move to accelerate…
Introduces FFPE-Compatible Barcoding Innovation Enabling Whole Transcriptome Single-Cell Analysis Parse Biosciences, a subsidiary of QIAGEN and a recognized leader in scalable single-cell sequencing technologies, has announced the commercial launch and…
Omeros Corporation Releases Fourth Quarter and Full-Year 2025 Financial Results Omeros Corporation has reported a transformative set of financial and operational results for the fourth quarter and full year ended…
GE HealthCare Advises Shareholders to Reject Potemkin Limited’s “Mini-Tender” Proposal GE HealthCare Technologies Inc. has issued a formal response to an unsolicited “mini-tender” offer made by Potemkin Limited, urging its…
Tanner Pharma Group and Biodexa Introduce Global Early Access Initiative for Patients with Familial Adenomatous Polyposis (FAP) Tanner Pharma Group, a globally recognized provider of specialty medicine access solutions, has…
Sub-Q Bionics Raises $1.5 Million Pre-Seed Round to Accelerate Development of Next-Generation Lymphedema Care Technology Sub-Q Bionics, an emerging innovator in the medical device space, has taken a significant step…